Contents
Special Issue Topic

Old and New Paradigms in Viral Vaccinology

Submission Deadline: July 16, 2025

Guest Editors

Dr. Marc H.V. Van Regenmortel E-Mail

Retired Emeritus CNRS Director, School of Biotechnology, 300 Boulevard Sébastien Brant, 67412 ILLKIRCH, France

Research Keywords: General virology, immunochemistry of viruses, viral taxonomy, synthetic peptide vaccine, viral diagnostics, SPR biosensors

Dr. Vladimir N. Uversky E-Mail

Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., MDC 07 Tampa, Forida 33612, USA

Research Keywords: Protein folding, misfolding and non-folding, intrinsically disordered proteins (IDPs), spectroscopy, molecular biology, bioinformatics

About the Special lssue

Thomas Kuhn [1] in "The Structure of Scientific Revolutions" introduced the term paradigm to refer to the conceptual framework that scientists use when they try to solve a particular problem. A paradigm consists of a number of hypotheses, presuppositions and theoretical assumptions that guide the experimental approaches that scientists choose to follow in their investigations. These underlying assumptions are often not explicitly stated because they are not based on established certainties. A theory for instance always consists of a cluster of interrelated explanatory models of a scientific phenomenon together with a number of auxiliary hypotheses that must be present in order to link the models with actual systems in the real world [2, p 85]. A theory may then achieve a certain level of predictive success for explaining a phenomenon but it can never achieve absolute certainty and the history of science has indeed shown that many accepted theories were subsequently shown to be false when additional empirical evidence became available. This is often due to the fact that some of the auxiliary hypotheses that were supposed to be fulfilled when the theory was tested were in fact not valid. In addition, when a theory appears to be consistent with experimental evidence, this may simply be due to the fact that some of these hypotheses just happened to be fulfilled. This means that all scientific theories remain tentative and that further experimentation may always reveal that when certain testing conditions are modified, the theory no longer applies.

The logical positivists in the last century believed that inductive generalizations (for instance that all the swans we have ever seen are white) can be transformed by deduction into a valid scientific law that claims that every swan is necessarily white. Attempts to reach logical certainties by induction were eventually abandoned when it was admitted that if humans went on collecting additional empirical evidence, they might be forced to accept for instance that black swans also exist.

Few scientists today believe that scientific reasoning can lead to absolutely certain deductions and they resist the temptation of accepting that their current hypotheses, theories and paradigms are necessarily correct since they view them as logically uncertain assumptions that always need to be empirically verified. Although scientists in their investigations mostly operate within shared tentative paradigms and assumptions, when they obtain results that are incompatible with the paradigm, they tend to invent new ad-hoc hypotheses to rescue the paradigm rather than abandoning it because their main aim is not to prove the validity of their chosen paradigm. In vaccinology, the choice of a valid paradigm is particularly difficult because the extreme complexity of immune systems makes it difficult to guess what are the mechanisms that lead to the development of protective antibodies in vaccinees who are able of overcoming the detrimental activities of pathogens. Another motive that makes investigators retain a paradigm is that the human mind is prone to numerous psychological convictions and biases, for instance "confirmation bias" which leads scientists to give more weight to their favorite hypotheses or paradigms rather than to the negative results of their experiments when these are in blatant contradiction with the paradigm [3].

Since the so-called scientific method is no longer accepted to provide a reliable procedure for reaching scientific certainties [4], relying on valid paradigms for solving scientific problems is also no longer an essential condition that guarantees that a correct solution to a scientific problem will be found. The term paradigm nevertheless continues to be used for referring to a particular approach to try to solve scientific problems. Kuhn [1] himself admitted that he had never clearly defined the concept of paradigm with the result that the term was used in so many ways that it came to signify any dominant idea that binds a scientific community together. He subsequently proposed that "paradigm" should be replaced by "exemplar" to refer to exemplary instances of successful solutions for scientific problems. However, the term paradigm continued to be used in spite of its ambiguity and of its inability, for instance, to lead to an effective HIV-1 vaccine by rational design [5].

References:

1. Kuhn TS. The Structure of Scientific Revolutions. Chicago, IL: University of Chicago Press: 1962.

2. Giere RN. Explaining Science. Chicago, IL; University of Chicago Press: 1988.

3. Kahneman D. Thinking, Fast and Slow. Farrar, Strauss and Giroux, S.I. 2011.

4. Van Regenmortel MHV. Design in biology and rational design in vaccinology: A conceptual analysis. Methods;2021. https://doi.org/10.1016/j.met.2021.07.010

5. Van Regenmortel MHV. An outdated notion of antibody specificity is one the major detrimental assumptions of the structure-based reverse vaccinology paradigm, which prevented it from developing an effective HIV-1 vaccine. Front Immunol. 2014;5:593. https://doi.org/103389/fimmu. 2014.00593

Keywords: Paradigm, temptation, vaccine

Published Articles

Open Access Review
Filoviridae: insights into immune responses to Ebola virus
Brent Brown ... Ingo Fricke
Published: April 25, 2024 Explor Immunol. 2024;4:238–266
3637 82 4
Open Access Review
Exploring the possible link between the spike protein immunoglobulin G4 antibodies and cancer progression
Mikolaj Raszek ... Alberto Rubio-Casillas
Published: April 25, 2024 Explor Immunol. 2024;4:267–284
26098 508 2
Open Access Review
Paradigm of immune dysregulation in coronavirus disease-2019 infection
Om Saswat Sahoo ... Subhradip Karmakar
Published: January 31, 2024 Explor Immunol. 2024;4:1–33
1810 23 3
Open Access Review
Immunopathogenesis of Orthopoxviridae: insights into immunology from smallpox to monkeypox (mpox)
Brent Brown ... Enrique Chacon-Cruz
Published: November 21, 2023 Explor Immunol. 2023;3:525–553
5727 117 8
Open Access Review
Effect of coronavirus disease 2019 on the vaccine development paradigm
Sezer Okay
Published: October 10, 2023 Explor Immunol. 2023;3:433–441
1919 16 3
Open Access Review
The emergence of nanovaccines as a new paradigm in virological vaccinology: a review
Chittaranjan Baruah ... Bhabesh Deka
Published: August 31, 2023 Explor Immunol. 2023;3:361–383
3079 73 2
Open Access Review
Fight fire with fire: the need for a vaccine based on intrinsic disorder and structural flexibility
Vladimir N. Uversky
Published: October 31, 2022 Explor Immunol. 2022;2:731–748
2090 59 1
Open Access Review
Therapeutic and prophylactic applications of self-replicating RNA viruses
Kenneth Lundstrom
Published: May 18, 2022 Explor Immunol. 2022;2:264–292
3505 58 1
Open Access Review
A proposed new paradigm for an anti-AIDS tolerogenic vaccine
Christine Jacomet
Published: April 24, 2022 Explor Immunol. 2022;2:211–219
2102 23 0
Open Access Review
Paradigms in HIV vaccine research
Marc H.V. Van Regenmortel
Published: March 17, 2022 Explor Immunol. 2022;2:180–184
2018 39 0